ArticleBMC gastroenterology2023

Real-world systemic sequential therapy with regorafenib for recurrent hepatocellular carcinoma: analysis of 93 cases from a single center.

Qingwei Zhu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.